Increased responsiveness of mesolimbic and mesostriatal dopamine neurons to cocaine following repeated administration of a selective κ-opioid receptor agonist

Synapse

Volumn 30, Issue 3, 1998, Pages 255-262

  Heidbreder, Christian A ^a   Schenk, Susan ^b   Partridge, Brian ^b   Shippenberg, Toni S ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

opioid receptors; Caudate putamen; Cocaine; Nucleus accumbens

Indexed keywords

COCAINE; KAPPA OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BRAIN DEPTH STIMULATION; DOPAMINERGIC NERVE CELL; DRUG DEPENDENCE; DRUG RECEPTOR BINDING; HUMAN; LIMBIC CORTEX; LOCOMOTION; MALE; PRIORITY JOURNAL; RAT;

ANALGESICS; ANALYSIS OF VARIANCE; ANIMALS; BENZENEACETAMIDES; CAUDATE NUCLEUS; COCAINE; DOPAMINE; DRUG INTERACTIONS; KINETICS; LIMBIC SYSTEM; MALE; MICRODIALYSIS; MOTOR ACTIVITY; NEURONS; NUCLEUS ACCUMBENS; PUTAMEN; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; TIME FACTORS;

EID: 0031691534     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199811)30:3<255::AID-SYN3>3.0.CO;2-A     Document Type: Article

References (37)

1. Bronson, M.E., Lin, Y.P., Burchett, K., Picker, M.J., and Dykstra, L.A. (1993) Serotonin involvement in the discriminative stimulus effects of κ-opioids in pigeons. Psychopharmacology, 111:69-77.
2. Chavkin, C., James, I.F., and Goldstein, A. (1982) Dynorphin is a specific endogenous ligand of the κ-opioid receptor. Science, 215:413-415.
3. Collins, J.P., Lesse, H., and Lagan, L.W. (1979) Behavioral antecedents of cocaine-induced stereotypy. Pharmacol. Biochem. Behav., 11:683-687.
4. Creese, I., and Iversen, S.D. (1974) The role of forebrain dopamine systems in amphetamine-induced stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine. Psychopharmacology, 39:345-357.
5. Devine, D.P., Leone, P., Pocock, D., and. Wise, R.A. (1993) Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: In vivo microdialysis studies, J. Pharmacol. Exp. Ther., 266:1236.
6. Di Chiara, G., and Imperato, A. (1988a) Opposite effects of μ and κ-opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther., 244:1067
7. Di Chiara, G., and Imperato, A. (1988b) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA, 85:5274.
8. Glick, S.D., Maisonneuve, I.M., Raucci, J., and Archer, S. (1995) Kappa opioid inhibition of morphine and cocaine self-administration in rats. Brain Res., 681:147-152.
9. Hadfield, M.G., and Nuggent, E.A. (1983) Cocaine: Comparative effect on dopamine uptake in extrapyramidal and limbic systems. Biochem. Pharmacol., 32:744-746.
10. Heidbreder, C., and Shippenberg, T.S. (1994) U-69593 prevents cocaine sensitization by normalizing basal accumbens dopamine, NeuroReport, 5:1797.
11. Heidbreder, C.A., Goldberg, S.R., and Shippenberg, T.S. (1993) The κ-opioid receptor agonist U69593 attenuates cocaine-induced behavioral sensitization in the rat. Brain Res., 616:333-338.
12. Heidbreder, C.A., Babovic-Vuksanovic, D., Shoaib, M., and Shippenberg, T.S. (1995) Development of behavioral sensitization to cocaine: Influence of κ-opioid receptor agonists. J. Pharmacol. Exp. Ther., 275:150-163.
13. Hill, M.P., and Brotchie, J.M. (1995) Modulation of glutamate release by a κ-opioid receptor agonist in rodent and primate striatum. Eur. J. Pharmacol., 281:R1-R2.
14. Johanson, C.E., and Fischman, M.W. (1989) The pharmacology of cocaine related to its abuse. Pharmacol. Rev., 41:3-52.
15. Kalivas, P.W., and Duffy, P. (1990) The effect od acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse, 5:48-58.
16. Kehne, J.H., Sant, W.W., and Sorenson, C.A. (1981) The effects of radiofrequency lesions of the nucleus accumbens on d-amphetamine induced locomotor and rearing behavior in rats. Psychopharmacology, 75:363-367.
17. Kelly, P.H. (1977) Drug-induced motor behavior. Handbook Pharmacol., 8:295-331.
18. Kelly, P.H., and Iversen, S.D. (1976) Selective 6-OHDA induced destruction of mesolimbic dopamine neurons: Abolition of psychostimulant induced locomotor activity in rats. Eur. J. Pharmacol., 40:45-56.
19. Kelly, P.H., Seviour, P., and Iversen, S.D. (1975) Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens sept and corpus striatum. Brain Res., 94:507-522.
20. 3H] U69593, a highly selective ligand for the κ-opioid receptor. Eur. J. Pharmacol., 109:281-284.
21. Maisonneuve, I.M., Archer, S., and Glick, S.D. (1994) U50488, a κ-opioid receptor agonist, attenuates cocaine-induced increase in extracellular dopamine in the nucleus accumbens of rats. Neurosci. Lett., 181:57-60.
22. Marin, C., Engber, T.M., Chadhuri, P., Peppe, A., and Chase, T.N. (1996) Effects of κ-agonists on D1 and D2 dopamine agonist and antagonist-induced behaviors. Psychopharmacology, 213:215-221.
23. Morrow, B.A., and Roth, R.H. (1996) Serotonergic lesions alter cocaine-induced locomotor behavior and stress-activation of the mesocoorticolimbic dopamine system. Synapse, 23:174-181.
24. Paxinos, G., and Watson, C. (1986) The Rat Brain In Stereotaxic Coordinates. Academic Press, Sydney.
25. Randrup, A., Munkvad, I., and Usden, P. (1963) Adrenergic mechanisms and amphetamine induced abnormal behaviors. Acta Pharmacol. Toxicol., 20:145-157.
26. Reith, M.E.A, Meisler, B.E., Sershen, H., and Lajtha, A. (1986) Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce sterotyped behaviors. Biochem. Pharmacol., 35:1123-1129.
27. Richardson, N.R., and Roberts, D.C.S. (1991) Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the rat. Life Sci., 49:833-840.
28. Roberts, D.C.S. (1992) Neural substrates mediating cocaine reinforcement: The role of monamine systems. In: Cocaine, Pharmacology, Physiology and Clinical Studies. Lakoski, J.M., Galloway, M.P., and White, F.J., eds. Boca Raton: CRC Press, pp. 73-90.
29. Smith, J.A., Mo, Q., Guo, H., Kunko, P.M., and Robinson, S.E. (1995) Cocaine increases extraneuronal levels of aspartate and glutamate in the nucleus accumbens. Brain Res., 683:264-269.
30. Spanagel, R., Herz, A., and Shippenberg, T.S. (1990) The influence of opioid peptides on dopamine release in the nucleus accumbens: An in-vivo microdialysis study. J. Neurochem., 55:1734-1740.
31. Spanagel, R., Herz, A., and Shippenberg, T.S. (1992) Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. USA, 89:2046-2050.
32. Spealman, R.D., and Bergman, J. (1992) Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids. J. Pharmacol. Exp. Ther., 261:607-615.
33. Spealman, R.D., and Bergman, J. (1994) Opioid modulation of the discriminative stimulus effects of cocaine: comparison of mu, kappa and delta agonists in squirrel monkeys discriminating low doses of cocaine. Behav. Pharmacol., 5:21-31.
34. Thompson, A.C, Heidbreder, C.A., Acri, J.B., and Shippenberg, T.S (1996) Evidence that κ-opioid agonists induce long-term alterations in dopamine uptake and release, Proc. Int. Narc. Res. Conf., California.
35. Ukai, M., Mizutani, M., and Kameyama, T. (1994) Opioid peptides selective for receptor types modulate cocaine-induced behavioral responses in mice. Yakubutsu Seishin Kodo 14:153-159.
36. Walker, J.M., Thompson, L.A., Frascella, J., and Friederick, M.W. (1987) Opposite actions of mu and kappa opiates on the firing of dopamine cells in the rat substantia nigra. Eur. J. Pharmacol., 134:53-59.
37. Weiss, F., Markou, A., Lorang, M.T., and Koob, G.F. (1992) Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res., 593:314-318.